Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Neutron capture therapy for cancer]

H Fukuda1, M Ichihashi, Y Mishima

  • 1Institute of Development, Aging and Cancer, Tohoku University.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|February 1, 1994
PubMed
Summary

Boron neutron capture therapy (BNCT) effectively treated malignant melanoma in 14 patients using boron-10 phenylalanine (BPA). This selective radiotherapy achieved good tumor control with manageable skin reactions, indicating its therapeutic potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Continuous epidural infusion of bupivacaine and buprenorphine for postoperative pain relief].

Masui. The Japanese journal of anesthesiology·1992
Same author

[Sevoflurane anesthesia for asthmatic patients: report of five cases].

Masui. The Japanese journal of anesthesiology·1992
Same author

Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosa.

Antimicrobial agents and chemotherapy·1992
Same author

Identification of the binding site of 55kDa tumor necrosis factor receptor by synthetic peptides.

Biochemical and biophysical research communications·1992
Same author

Two reactions are simultaneously catalyzed by a single enzyme: the arginine-dependent simultaneous formation of two products, ethylene and succinate, from 2-oxoglutarate by an enzyme from Pseudomonas syringae.

Biochemical and biophysical research communications·1992
Same author

Molecular cloning in Escherichia coli, expression, and nucleotide sequence of the gene for the ethylene-forming enzyme of Pseudomonas syringae pv. phaseolicola PK2.

Biochemical and biophysical research communications·1992

Area of Science:

  • Oncology
  • Radiotherapy
  • Nuclear Medicine

Context:

  • Malignant melanoma presents a significant therapeutic challenge.
  • Boron neutron capture therapy (BNCT) offers a targeted approach to cancer treatment.
  • 10B-paraboronophylalanine (BPA) is a key compound for delivering boron-10 to melanoma cells.

Purpose:

  • To evaluate the efficacy and safety of BNCT for malignant melanoma.
  • To introduce the current status and methodology of BNCT in melanoma treatment.
  • To establish a therapeutic dosing strategy based on skin tolerance.

Summary:

  • BNCT utilizes boron-10 to generate cell-killing alpha particles upon neutron absorption.
  • 10B-paraboronophylalanine (BPA) was administered via injection or infusion for melanoma targeting.
  • Therapeutic doses were determined by maximum skin tolerance, approximated using blood concentration data.
  • Fourteen melanoma patients received BNCT, demonstrating good local tumor control and acceptable skin reactions.

Impact:

  • BNCT shows promise as an effective treatment for malignant melanoma.
  • The study highlights the feasibility of using skin tolerance for BNCT dosing.
  • Further research and clinical experience are needed to optimize BNCT for melanoma.

Related Experiment Videos